2023, Vol. 5, Issue 3, Part B

Methods: The study was conducted within the Department of General Medicine for the period of 1 year. In this study, a total of 300 patients diagnosed with Metabolic Syndrome (MetS) were included for enrollment.

Results: In this study, a total of 300 patients diagnosed with Metabolic Syndrome (MetS) were included for enrollment. In both groups, there was a prevalence of female dominance over males. The mean height in the first group was 164.0±9.01, while in the second group it was 161.9±8.52. The mean weight in the groups was 79.4±13.13 and 75.8±12.29, respectively. Among the cohort of 300 patients diagnosed with Metabolic Syndrome (MetS), it was observed that 60 individuals (20%) presented with hypothyroidism, while 6 individuals (2%) exhibited overt hyperthyroidism.

Conclusion: The observed prevalence of thyroid dysfunction (TD) among patients diagnosed with metabolic syndrome (MetS) was found to be significantly elevated, suggesting a potential correlation between thyroid function and MetS. The data obtained from the current study will assist in establishing a correlation between thyroid dysfunction (TD) and metabolic syndrome (MetS). The early identification of TD in individuals with MetS would be beneficial for implementing timely interventions, such as lifestyle modifications, to potentially alter the progression of the disease.